Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
American Association of Clinical Endocrinologists (AACE) 2018
May 16 - 20, 2018; Boston, Massachusetts
May 16 - 20, 2018Boston, Massachusetts
AACE 2018Thyroid Nodule Location Linked to Malignancy Risk Thyroid nodules located in the upper pole of the gland were nearly five-times more likely to be malignant, suggesting possible anatomical or environmental influences.
Medscape Medical News, May 20, 2018
AACE 2018Cabozantinib Looks Promising for Malignant PheochromocytomaTyrosine kinase inhibitor may offer several benefits to patients with malignant pheochromocytomas and paragangliomas, very rare forms of cancer that are difficult to treat.
Medscape Medical News, May 19, 2018
AACE 2018Simple Ratio May Predict Fracture Risk in Obese Patients Bone mineral density divided by body mass index could offer a simple way of predicting fracture risk in those overweight or obese, and may outperform the trabecular bone score.
New AACE Lipid Guidelines Establish 'Extreme' CVD Risk CategoryReverting back to LDL targets, the American Association of Clinical Endocrinologists/American College of Endocrinology advise
less than 55 mg/dL for those at extremely high risk for CV events
Medscape Medical News, May 05, 2017
Topical Testosterone Adherence Low Among Hypogonadal MenA large study finds adherence is higher in hypogonadal men if testosterone is prescribed by a specialist. Those with more
comorbidities are less likely to be compliant, however.
Medscape Medical News, May 11, 2017
Gene Classifier 'Great Rule-Out Test' for Thyroid-Nodule SurgeryOne of the longest follow-up studies to date shows the Afirma test prevented a third of unnecessary thyroid-nodule surgeries
and can be used to rule out cancer. But an outside commentator says situation is nuanced.
